|
DUSP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.650240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.144830E-01 |
| Normal-vs-Stage2 |
9.281200E-01 |
| Normal-vs-Stage3 |
1.334210E-02 |
| Normal-vs-Stage4 |
5.482000E-01 |
| Stage1-vs-Stage2 |
3.539600E-01 |
| Stage1-vs-Stage3 |
5.261600E-02 |
| Stage1-vs-Stage4 |
8.720000E-01 |
| Stage2-vs-Stage3 |
1.233200E-01 |
| Stage2-vs-Stage4 |
5.786800E-01 |
| Stage3-vs-Stage4 |
4.293600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.468400E-01 |
| Normal-vs-AfricanAmerican |
2.402000E-02 |
| Normal-vs-Asian |
2.133200E-01 |
| Caucasian-vs-AfricanAmerican |
7.647900E-02 |
| Caucasian-vs-Asian |
6.444600E-01 |
| AfricanAmerican-vs-Asian |
2.766600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.156340E-02 |
| Normal-vs-Female |
3.684400E-01 |
| Male-vs-Female |
1.246380E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.077400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.600100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.197600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.839800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.303640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.855600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.246200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.343800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.223600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.382000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.99270000003737E-06 |
| Classical-VS-Follicular |
1.88338999999038E-05 |
| Classical-VS-Other |
1.589070E-04 |
| Classical-VS-Normal |
5.619200E-01 |
| Tall-VS-Follicular |
6.065600E-01 |
| Tall-VS-Other |
1.815160E-01 |
| Tall-VS-Normal |
1.181480E-03 |
| Follicular-VS-Other |
3.832600E-01 |
| Follicular-VS-Normal |
8.198800E-04 |
| Other-VS-Normal |
3.020800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.599900E-02 |
| Normal-vs-N1 |
2.317800E-01 |
| N0-vs-N1 |
5.649600E-01 |
|
|
